For the year ending 2025-12-31, ANIK made $112,819K in revenue. -$9,056K in net income. Net profit margin of -8.03%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 112,819 | |||
| Cost of revenue | 49,012 | |||
| Gross profit | 63,807 | |||
| Research & development | 25,770 | |||
| Selling, general & administrative | 49,088 | |||
| Total operating expenses | 74,858 | |||
| (loss) income from operations | -11,051 | |||
| Interest and other income, net | 1,744 | |||
| (loss) income before income taxes | -9,307 | |||
| Provision for income taxes | 672 | |||
| Loss from continuing operations | -9,979 | |||
| Loss from discontinued operations, net of tax | -901 | |||
| Net loss | -10,880 | |||
| Foreign currency translation adjustment | 1,824 | |||
| Comprehensive loss | -9,056 | |||
| Basic EPS | -0.76 | |||
| Diluted EPS | -0.76 | |||
| Basic Average Shares | 14,339,000 | |||
| Diluted Average Shares | 14,339,000 | |||
Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK)